The natriuretic effect of dopamine-1 (DA-1) agonists is reduced in spontaneously hypertensive rat (SHR), partly because of defective DA-1 receptor-adenylate cyclase (AC) coupling in renal proximal convoluted tubules. To investigate this defective coupling, DA-1 dopamine receptors from renal proximal tubules were solubilized and reconstituted into phospholipid vesicles.
Introduction
Dopamine exerts its biological effects through occupation of specific receptor subtypes. In the central nervous system and certain endocrine organs, the dopamine receptors are classified into the D-l or D-2 subtypes on the basis of their ability to either stimulate or inhibit adenylate cyclase (AC),' respectively (1) . These receptors have been cloned, including novel D-3, D-4, and D-5 dopamine receptors (2) (3) (4) (5) (6) (7) (8) (9) (10) . In peripheral tissues, these receptors have been designated as DA-l and DA-2 (11) .
The receptors in both the central nervous system and in peripheral tissues have marked similarities and some differences, the most notable of which is the lower affinity of the renal dopamine receptor than ofthe brain dopamine receptor for dopaminergic drugs (12, 13) . Indeed, the RNA for the cloned brain dopamine receptors has not been detected in the kidney, except (maybe) for the D-3 dopamine receptor (8) .
The molecular mechanisms of dopamine action on DA-1 dopamine receptors in the kidney and the series of events that leads to physiological responses are beginning to be elucidated. In the kidney, there is evidence that dopamine, which is produced in the proximal tubule, increases sodium excretion by inhibition of Na+/H' antiport activity via cAMP (14) . Dopamine also inhibits Na+/K' ATPase activity (15) and this effect is apparently mediated by protein kinase C (16) . In renal tissue, DA-l agonists stimulate phospholipase C (17, 18) .
We recently reported the existence of abnormalities in the renal dopaminergic system in the genetically hypertensive rat (spontaneously hypertensive rat; SHR) of the Okamoto Aoki strain (19) . We also demonstrated that the natriuretic and the antinatriuretic effects ofDA-1 agonists and antagonists, respectively, were reduced in the SHR but not in normotensive rat controls (Wistar-Kyoto rat; WKY) (20) . In the SHR, both the potency ofDA-I -selective agonists to compete for binding sites on the receptor and the ability ofthese agonists to stimulate AC were vastly diminished. The decreased ability ofDA-1 agonists to stimulate AC activity was not due to a defective AC enzyme per se but rather to a defective DA-l receptor-AC coupling mechanism (19) . To investigate the mechanism for the defective DA-l dopamine receptor in the SHR and to develop a cell-free system (21, 22) MO) , whereas SM-2 Bio-Beads were from Bio-Rad Laboratories (Richmond, CA). Dulbecco's PBS (DPBS) was purchased from Gibco Laboratories (Grand Island, NY). All other reagents were of the highest purity commercially available. 20-wk-old WKY and SHR (Okamoto-Aoki strain) were purchased from Taconic Farms, Inc., (Germantown, NY).
Membranepreparation. Renal cortical tubules enriched with proximal tubules were prepared as previously described, with modifications Solubilized Renal Dopamine-l Receptors in Hypertensive Rats 789 (23) . In brief, the rats were anesthetized with pentobarbital (50 mg/kg i.p.) and the kidneys exposed via a midline abdominal incision. A polyethylene catheter was inserted into the abdominal aorta just above the bifurcation into the iliac arteries. A direct blood pressure recording was obtained to verify the elevated systolic arterial pressure in the SHR (185-2 10 mmHg) and normal pressure in the WKY (135-145 mmHg).
The kidneys were perfused with 25 ml of Ca2'-free PBS, pH 7.4, with collagenase (30 mg, Sigma type IV). The kidneys were then excised and the cortex isolated from the medulla. The cortical tissue, which was minced to a fine paste, was passed successively through a series of stainless steel sieves (Newark Wire Cloth Co., Newark, NJ) (in order: 212, 85, and 75 jim). The tubules (from the 85-jim sieve) were resuspended in ice-cold DPBS and allowed to settle by gravity for 30 min. The resulting pellet contained mainly proximal tubular cells, as ascertained by AC activation by DA-I agonists and parathyroid hormone (19) , alkaline and acid phosphatase determinations, and light microscopic examination (23) . The tubules were free of glomeruli, as determined by acid phosphatase determinations and by light microscopic examination (23) . In addition, most ofthe tubules took up fluorescein, which is characteristic of proximal but not distal tubular cells (24) . Moreover, these tissues behaved in a fashion consistent with proximal convoluted tubules (PCT) obtained from WKY and SHR (19) . The only other cortical tubule with AC-linked DA-l dopamine receptor is present in the cortical collecting duct (12) . However, the coupling of DA-I dopamine receptors in the cortical collecting duct to AC is similar in WKY and SHR (25) . Viability was determined by the failure of cells to take up 1% trypan blue (23) .
The proximal tubules were homogenized at a protein concentration of 1 mg/ml in 10mM Tris-HCl, pH 7.4, containing protease inhibitors (1 mM PMSF, 1 mM EDTA, and 5 jg/ml each of leupeptin and pepstatin). Cellular debris and nuclei were pelleted at 270 g for 5 min, and the resulting supernatant was centrifuged at 18,000 g for 20 min to pellet membranes. The crude membranes were washed once and were either used immediately or stored frozen in small aliquots at -80'C in 10 mM Tris HC1, pH 7.4, 5 mM MgCI2, and 250 mM sucrose (26).
Solubilization and reconstitution. Proximal tubular membranes were solubilized by 1% sodium cholate, after pretreatment with 10 jM SKF R-38393, essentially as described before for rat striatal D-1 dopamine receptors (21, 22) . Briefly, membranes were suspended at 1-2 mg/ml in buffer A (50 mM Tris-HCI, pH 7.4, 120 mM NaCl, 5 mM KCI, 2 mM CaC12, and 1 mM MgCI2) in the presence of 10 jM SKF R-38393, a D-l selective agonist. After 20 min at 37°C, the membranes were centrifuged and suspended in solubilizing buffer (50 mM Tris-HCI, pH 7.4,5 mM KCI, 2 mM CaCI2, 1 mM MgCI2, 250 mM sucrose, 1 mM EDTA, 1.5 mM PMSF, and 1 mM DTT). In some studies, as noted in the legends to figures, 1 M NaCl was included in the solubilizing buffer. Sonicated phospholipids were added to a final concentration of 1.2 mg/ml and sodium cholate was added to a final concentration of 1%. After a 15-20-min incubation on ice, the mixture was centrifuged at 31,300 g for 45 min. The clear supernatant obtained after high-speed centrifugation was stored frozen in small aliquots at -80°C (22, 27) .
For reconstitution of soluble DA-I dopamine receptors into phospholipid vesicles, sonicated phospholipids (20 mg/ml) were readded to the soluble extract to a final concentration of 1.2 mg/ml. Protease inhibitors (1 mM PMSF and 5 jg/ml each of leupeptin and pepstatin) were added directly to the soluble extracts before addition of phospholipids (26) . Cholate was removed by the addition of moist SM-2 Bio-Beads (1.2 g/ml ofextract), and the mixture was shaken gently for 1 h at 4°C. After the beads were allowed to settle, the turbid supernatant containing the proteoliposomes was aspirated and used directly in binding studies.
Radioligand binding assays. For Otherprocedures. Protein was determined by the method ofLowry et al. (30) . The computer-fitted program LIGAND (31) was used to analyze the binding data. In each case, a two-site model was considered to be a better fit according to the F test at P < 0.05. All values are summarized as means±SEM from two to six separate experiments.
Results
['25I]SCH 23982 binding to solubilized and reconstituted receptorpreparations. We had earlier demonstrated that, on solubilization and reconstitution of brain D-1 dopamine receptors into phospholipid vesicles, the agonist high-affinity sites were potentiated and comprised 40-50% ofthe total receptor population (21, 22) . These potentiated sites were due to increased coupling of receptor to G protein and were abolished by guanine nucleotide analogues. We decided to use a similar approach to study the guanine nucleotide-sensitive agonist highaffinity DA-1 sites in proximal tubules of normotensive WKY and hypertensive SHR rats.
DA-1 dopamine receptors from proximal tubules of WKY rats were extracted in the presence of 1 M NaCl and reconstituted into phospholipid vesicles, as described under Methods. The binding of the DA-1 dopamine-selective ligand ['251 ]SCH 23982 to the reconstituted DA-1 dopamine receptors was specific and saturable (Fig. 1) . Specific binding represented the bulk of total binding; nonspecific binding, defined as binding in the presence of 10 uM ofthe DA-1 receptor-selective antagonist SCH 23390, was between 25 and 40% of total binding. Scatchard analysis (Fig. 1, inset) ofthe saturation data revealed that the ligand bound to a single site with an apparent Kd of 15.3±8.5 nM and a maximum specific binding (B..) of 663.0±142.3 fmol/mg of protein, which represents a slight enrichment over the PCT membranes of WKY rats (479.1±22.2 fmol/mg protein) (19) . This increase in specific activity suggests a partial purification of the DA-1 dopamine receptors on solubilization, possibly because ofloss ofcellular proteins. The results also suggest that this method of solubilization and reconstitution is well suited for extracting DA-1 dopamine receptors from PCT.
Similar results were also obtained with DA-1 dopamine receptors extracted from proximal tubular membranes of the SHR (Fig. 2) . Accordingly, after solubilization and reconstitution of SHR receptors, the Scatchard analysis (Fig. 2, inset) Fig. 3 and Table I ). Competition curves with the DA-1 dopamine-selective antagonist SCH 23390 were monophasic, with a Ki value of 731 ± 130 nM (Table I) . Absence ofguanine nucleotide-sensitive agonist high-affinity sites in reconstituted DA-J dopamine receptors from SHR. DA-l dopamine receptors from proximal tubules ofSHR were solubilized and reconstituted into phospholipid vesicles in the absence of sodium chloride. Agonist competition curves of these reconstituted receptors from SHR were monophasic, and the Ki of binding of SKF R-38393 was 13,800±500 nM, corresponding to the low-affinity state of the receptor (Fig. 4) . Further, this affinity state was not due to coupling to G proteins, since in the presence of 100,gM Gpp(NH)p, the Ki was virtually unaffected (Table I ). These data suggest that the SHR DA-1 dopamine receptor is unable to couple to G proteins under the present experimental conditions. This aberrant coupling between receptor and G protein occurs in conditions that proaw... 
